Parallel Advisors »

Bicara Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $716 36 19.89

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Corcept Therapeutics Stock (CORT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Microsoft Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Amazon.com Stock (AMZN)
Avantis International Equity Etf Etf (AVDE)
Cvb Finl Corp Stock (CVBF)
Vanguard Large Cap Etf (VV)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Victoryshares Free Cash Flow Etf Etf (VFLO)

View all positions for Parallel Advisors

Top funds holding Bicara Therapeutics

RA Capital Management
Vestal Point Capital
Siren
Deep Track Capital
FMR
Henderson Group
T. Rowe Price Investment Management
Red Tree Management
Tpg Gp A
BlackRock
Omega Fund Management
Vanguard Group
Vanguard Capital Management
Citadel Advisors
State Street Corporation

View all funds holding Bicara Therapeutics